美股新聞 標題聯播 · 近 24 小時 337 則 · 29 個來源 · 最新 9/20 04:53
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · NVAX近 30 天 22 則 · 第 1 / 1 頁
- Novavax (NVAX) 表現超越大盤漲勢：投資人需知Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know
- Novavax (NVAX) Soars 7.0%: Is Further Upside Left in the Stock?
- Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher
- Novavax (NVAX) Could Be 32% Above Fair Value On Medicare Policy Fears
- Do Novavax’s (NVAX) New Partnerships Offset Policy Risks From The Protecting Approved Care Act?
- Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know
- Is Cancer the Turnaround Moderna Has Been Looking for Post-COVID?
- Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
- Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know
- Novavax (NVAX) Laps the Stock Market: Here's Why
- 3 Russell 2000 Stocks We’re Skeptical Of
- Novavax Highlights Sanofi, Pfizer Catalysts in Matrix-M Platform Pivot
- Novavax Highlights Matrix-M Licensing Push, Oncology Ambitions at Cantor Conference
- 3 of Wall Street’s Favorite Stocks with Open Questions
- Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva
- 1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
- Novavax to Participate in September Investor Conferences
- Novavax Jumps 6% on Matrix-M Oncology Speculation: Is the Royalty Model the Real Story?
- How Expanded Nuvaxovid Royalties and Partner-led Execution Could Shape Novavax’s (NVAX) Investment Narrative
- Novavax (NVDA) Following Updated Nuvaxovid Approval Faces A Wide Fair Value Debate
- Stocks making big moves this week: Bally's, Adobe, Novavax, Semtech, and STAAR Surgical
- SLS, IBRX Stocks In Focus: Analyst Says Moderna-Merck Cancer Vaccine Success ‘Bodes Well’ For Oncology
- Novavax (NVAX) Reports Q2 Loss, Tops Revenue Estimates
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。